Long-Term Safety of Anti-TNF Adalimumab in HBc Antibody-Positive Psoriatic Arthritis Patients: A Retrospective Case Series of 8 Patients
Immunosuppressive drugs commonly used in the treatment of psoriatic arthritis make patients more susceptible to viral, bacterial, and fungal infections because of their mechanism of action. They not only increase the risk of new infections but also act altering the natural course of preexisting infe...
Saved in:
| Main Authors: | R. Laurenti, F. Giovannangeli, E. Gubinelli, M. T. Viviano, A. Errico, L. Leoni, E. Ballanti, A. Migliore |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2013/410521 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adalimumab in treatment of psoriatic arthritis
by: V. V. Badokin
Published: (2008-08-01) -
Comparative efficacy of tofacitinib and adalimumab in patients with psoriatic arthritis in real clinical practice. Data from the Russian nationwide register of patients with psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2021-06-01) -
THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01) -
Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
by: V. V. Didenko, et al.
Published: (2021-05-01) -
EXPERIENCE OF APPLYING MONOCLONAL ANTIBODIES TO TNF α — ADALIMUMAB — IN A CHILD WITH JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)